Join the COVID-19 Clinical Research Coalition and Epidemics Ethics on a webinar to discuss how the COVID-19 pandemic has intensified the need for timely, rigorous, and accessible scientific evidence to guide the development of diagnostics, therapeutics, and vaccines. Such research often takes place in collaboration between partners across the world and is then subjected to multiple layers of ethics review. Staggered ethics review risks delaying research, increasing administrative burdens, and applying inconsistent protections to study populations, while not increasing protections for research participants.
Ethics Review Mutual Recognition
Ethics review mutual recognition refers to a system where the decisions of one Research Ethics Committee are accepted by another on the basis of shared procedural standards.
This one-hour webinar will share the findings of a project* undertaken in collaboration with the Ethics Working Group of the COVID-19 Clinical Research Coalition to review the challenges and opportunities of ethics review mutual recognition for COVID-19 multi-site research protocols.
* With thanks to the World Health Organization for funding
– Introduction – Prof. Jantina de Vries, University of Cape Town, South Africa & co-chair of the coalition’s Ethics Working Group
– Ethics review mutual recognition: opportunities and lessons learnt during the COVID-19 pandemic – Dr Vasiliki Rahimzadeh, Stanford University, USA
– Response by Prof. Kevin Marsh, Oxford University & African Academy of Sciences, UK
– Response by Dr Dicky Akanmori, WHO Africa Regional Office, Republic of the Congo
– Panel discussion and Q&A with Prof. Marsh, Dr Akanmori, and Ms Katherine Littler, WHO, Switzerland
Feb 18, 2021 04:00 PM in Amsterdam, Berlin, Rome, Stockholm, Vienna
Call to Action: Follow the link to register to this important Webinar. Webinar Registration – Zoom